The protective effects of endothelin-A receptor antagonist BQ-123 in pentylenetetrazole-induced seizure in rats      
Yazarlar (5)
H. Erdogan
Tekirdağ Namık Kemal Üniversitesi, Türkiye
F. Ekici
Ankara Yildirim Beyazit University, Türkiye
Doç. Dr. Muzaffer KATAR Tokat Gaziosmanpaşa Üniversitesi, Türkiye
H. Kesici
Tokat Gaziosmanpaşa Üniversitesi, Türkiye
H. Aslan
Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Makale Türü Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale
Dergi Adı Human and Experimental Toxicology
Dergi ISSN 0960-3271 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Dergi Grubu Q3
Makale Dili İngilizce
Basım Tarihi 01-2014
Cilt No 33
Sayı 10
Sayfalar 1008 / 1016
DOI Numarası 10.1177/0960327113520017
Makale Linki http://journals.sagepub.com/doi/10.1177/0960327113520017
Özet
Endothelin-1 has been shown to increase neuronal activity and glutaminergic synaptic transmission by endothelin-A receptors (ETAR) in the nucleus tractus solitarius neurons that play an important role in epileptic seizures. Therefore, BQ-123 as an ETAR antagonist might attenuate neuronal excitability and glutaminergic synaptic transmission. The main purpose of the present study is to investigate the protective effect of acute BQ-123 treatment against pentylenetetrazole (PTZ)-induced tonic–clonic seizures. Wistar albino rats were divided into three groups: control, PTZ, and PTZ + BQ-123 groups. BQ-123 (3 mg/kg, intravenously) was administered for 15 min before injecting with PTZ (50 mg/kg, intraperitoneally). We determined a delay resulting from BQ-123 in “duration of the seizure onset.” “Number of rats with major seizure” also decreased according to scoring with video camera in PTZ + BQ-123 group. In BQ …
Anahtar Kelimeler
BQ-123 | endothelin receptor antagonist | Pentylenetetrazole | seizure